Cell Growth & Differentiation, Vol 9, Issue 5 405-413, Copyright © 1998 by American Association of Cancer Research

ARTICLES

Redistribution and enhanced protein kinase C-mediated phosphorylation of alpha- and gamma-adducin during renal tumor progression

L Fowler, J Everitt, JL Stevens and S Jaken
Adirondack Biomedical Research Institute, Lake Placid, New York 12946, USA.

Tumor promotion/progression is known to be due in part to increased signaling through a variety of mitogenic pathways, including protein kinase C (PKC). To determine whether increased PKC activity could play a role in promotion and progression of renal cancer, we monitored PKC activity in normal and progressively transformed renal neoplasias from Eker rats. Eker rats carry a defect in the tumor suppressor TSC2 gene that predisposes them to renal carcinoma, whereas additional factors influence tumor promotion/progression in accordance with a "two-hit" model. We used the phosphorylation of adducins at Ser-660, a known PKC phosphorylation site, as a reporter for endogenous PKC activity. In normal proximal tubules, total adducin levels (measured with a phosphorylation state-insensitive antibody) were relatively high, whereas pSer660-adducin (measured with a phosphorylation state-sensitive antibody) levels were very low. In comparison, in renal carcinomas, total adducin levels were decreased, and pSer-660-adducin levels were increased. Changes in phosphorylation correlated with changes in localization. In normal tissue, alpha- and gamma-adducin are targeted to the apical and basal membranes of proximal tubules, respectively, implying unique functions for these related proteins. In early lesions (atypical tubules), differential targeting is lost, and both alpha- and gamma-adducins localize to the basal membrane. In more advanced lesions, staining in lateral membranes at cell-cell contacts becomes apparent. Furthermore, in cells that have lost basement membrane contact, plasma membrane targeting is no longer apparent. These changes in adducin expression levels, phosphorylation state, and localization parallel the increased growth potential and dedifferentiation of the progressive tumor phenotypes. These data demonstrate the utility of phosphorylation state-selective antibodies in immunohistochemical applications as reporters of endogenous PKC activity in tissue samples. We also provide the first evidence that increased PKC activity and phosphorylation of important target proteins occurs during progressive transformation in a non-phorbol ester tumor promotion model in vivo.

This article has been cited by other articles:

				H.-D. Je, C. Gallant, P. C. Leavis, and K. G. Morgan Caveolin-1 regulates contractility in differentiated vascular smooth muscle Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H91 - H98. [Abstract] [Full Text] [PDF]

				J. van den Boom, M. Wolter, R. Kuick, D. E. Misek, A. S. Youkilis, D. S. Wechsler, C. Sommer, G. Reifenberger, and S. M. Hanash Characterization of Gene Expression Profiles Associated with Glioma Progression Using Oligonucleotide-Based Microarray Analysis and Real-Time Reverse Transcription-Polymerase Chain Reaction Am. J. Pathol., September 1, 2003; 163(3): 1033 - 1043. [Abstract] [Full Text] [PDF]

				K. M. Lounsbury, M. Stern, D. Taatjes, S. Jaken, and B. T. Mossman Increased Localization and Substrate Activation of Protein Kinase C{delta} in Lung Epithelial Cells following Exposure to Asbestos Am. J. Pathol., June 1, 2002; 160(6): 1991 - 2000. [Abstract] [Full Text] [PDF]

				A. Alt, M. Ohba, L. Li, M. Gartsbein, A. Belanger, Mitchell. F. Denning, T. Kuroki, S. H. Yuspa, and T. Tennenbaum Protein Kinase C{{delta}}-mediated Phosphorylation of {{alpha}}6{beta}4 Is Associated with Reduced Integrin Localization to the Hemidesmosome and Decreased Keratinocyte Attachment Cancer Res., June 1, 2001; 61(11): 4591 - 4598. [Abstract] [Full Text] [PDF]

				E. A. Sausville, S. G. Arbuck, R. Messmann, D. Headlee, K. S. Bauer, R. M. Lush, A. Murgo, W. D. Figg, T. Lahusen, S. Jaken, et al. Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms J. Clin. Oncol., April 15, 2001; 19(8): 2319 - 2333. [Abstract] [Full Text] [PDF]

				D. RON and M. G. KAZANIETZ New insights into the regulation of protein kinase C and novel phorbol ester receptors FASEB J, October 1, 1999; 13(13): 1658 - 1676. [Abstract] [Full Text]

				S. C. Kiley, K. J. Clark, M. Goodnough, D. R. Welch, and S. Jaken Protein Kinase C {{delta}} Involvement in Mammary Tumor Cell Metastasis Cancer Res., July 1, 1999; 59(13): 3230 - 3238. [Abstract] [Full Text] [PDF]

				C. Chapline, J. Cottom, H. Tobin, J. Hulmes, J. Crabb, and S. Jaken A Major, Transformation-sensitive PKC-binding Protein Is Also a PKC Substrate Involved in Cytoskeletal Remodeling J. Biol. Chem., July 31, 1998; 273(31): 19482 - 19489. [Abstract] [Full Text] [PDF]

				B. van de Water, I. B. Tijdens, A. Verbrugge, M. Huigsloot, A. A. Dihal, J. L. Stevens, S. Jaken, and G. J. Mulder Cleavage of the Actin-capping Protein alpha -Adducin at Asp-Asp-Ser-Asp633-Ala by Caspase-3 Is Preceded by Its Phosphorylation on Serine 726 in Cisplatin-induced Apoptosis of Renal Epithelial Cells J. Biol. Chem., August 11, 2000; 275(33): 25805 - 25813. [Abstract] [Full Text] [PDF]